• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼患者小梁切除术联合丝裂霉素C前后眼压的波动情况

Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C.

作者信息

Wasielica-Poslednik Joanna, Schmeisser Julian, Hoffmann Esther M, Weyer-Elberich Veronika, Bell Katharina, Lorenz Katrin, Pfeiffer Norbert

机构信息

Department of Ophthalmology, University Medical Center, Johannes Gutenberg- University, Mainz, Germany.

Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, Mainz, Germany.

出版信息

PLoS One. 2017 Oct 4;12(10):e0185246. doi: 10.1371/journal.pone.0185246. eCollection 2017.

DOI:10.1371/journal.pone.0185246
PMID:28977004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5627910/
Abstract

PURPOSE

Intraocular pressure (IOP) fluctuation is considered as a risk factor for glaucoma progression. We investigated IOP values and IOP fluctuation before and after trabeculectomy (TE) with mitomycin C (MMC) measured by 48-hour diurnal-nocturnal-IOP-profiles (DNP).

METHODS

Pre- and postoperative DNPs of 92 eyes undergoing primary TE with MMC were analysed. Each 48-hour IOP-profile involved 10 IOP measurements (8:00 a.m., 2:00 p.m., 6:00 p.m., and 9:00 p.m. in sitting and at 00:00 in supine position). The "preoperative DNP" was performed a few weeks before TE. The "postoperative DNP" was performed at least six months (range: 6 months-2 years) after TE. Mean IOP values and IOP fluctuations were calculated.

RESULTS

After TE with MMC mean IOP was reduced from 16.94±3.83 to 11.26±3.77 mmHg at daytime and from 18.17±4.26 to 11.76±3.90 mmHg at night. At daytime mean IOP-fluctuation decreased from 8.61±4.19 to 4.92±2.52 mmHg, at night from 3.15±2.95 to 1.99±1.82 mmHg. Mean IOP was lower on the second day of the preoperative DNP. This effect was not present in the postoperative DNP. Preoperatively, IOP was controlled in all eyes with a mean of 3.22±0.94 antiglaucomatous agents. Postoperatively, IOP≤15 mmHg was achieved in 71.7%, IOP≤18 mmHg in 77.1% and a decrease in IOP of >30% in 47.8% without antiglaucomatous therapy. Postoperatively, pseudophakia was associated by a higher mean IOP-fluctuation compared to the phakic eyes.

CONCLUSIONS

TE with MMC significantly reduces both mean IOP-values and IOP- fluctuations at day and night at least 6 months postoperatively. The effect of TE on the IOP fluctuation was less pronounced in pseudophakic eyes.

摘要

目的

眼压(IOP)波动被认为是青光眼进展的一个危险因素。我们通过48小时昼夜眼压剖面图(DNP)研究了小梁切除术(TE)联合丝裂霉素C(MMC)前后的眼压值和眼压波动情况。

方法

分析了92例行原发性TE联合MMC治疗的患眼的术前和术后DNP。每48小时眼压剖面图包括10次眼压测量(上午8:00、下午2:00、下午6:00和晚上9:00坐位时测量,仰卧位0:00时测量)。“术前DNP”在TE前几周进行。“术后DNP”在TE后至少6个月(范围:6个月至2年)进行。计算平均眼压值和眼压波动情况。

结果

TE联合MMC治疗后,白天平均眼压从16.94±3.83 mmHg降至11.26±3.77 mmHg,夜间从18.17±4.26 mmHg降至11.76±3.90 mmHg。白天平均眼压波动从8.61±4.19 mmHg降至4.92±2.52 mmHg,夜间从3.15±2.95 mmHg降至1.99±1.82 mmHg。术前DNP第二天平均眼压较低。术后DNP中不存在这种效应。术前,所有患眼眼压均通过平均3.22±0.94种抗青光眼药物得到控制。术后,71.7%的患眼眼压≤15 mmHg,77.1%的患眼眼压≤18 mmHg,47.8%的患眼在未使用抗青光眼治疗的情况下眼压降低>30%。术后,与有晶状体眼相比,人工晶状体眼的平均眼压波动更高。

结论

TE联合MMC可在术后至少6个月显著降低昼夜平均眼压值和眼压波动。TE对人工晶状体眼眼压波动的影响不太明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/4ee8a34c18b3/pone.0185246.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/e4e3ca9e92b0/pone.0185246.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/d52edebffe41/pone.0185246.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/d37f0a034daa/pone.0185246.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/57dba1fbb784/pone.0185246.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/69b21f3d2029/pone.0185246.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/50b2fa2c09ad/pone.0185246.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/4ee8a34c18b3/pone.0185246.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/e4e3ca9e92b0/pone.0185246.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/d52edebffe41/pone.0185246.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/d37f0a034daa/pone.0185246.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/57dba1fbb784/pone.0185246.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/69b21f3d2029/pone.0185246.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/50b2fa2c09ad/pone.0185246.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bea/5627910/4ee8a34c18b3/pone.0185246.g007.jpg

相似文献

1
Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C.青光眼患者小梁切除术联合丝裂霉素C前后眼压的波动情况
PLoS One. 2017 Oct 4;12(10):e0185246. doi: 10.1371/journal.pone.0185246. eCollection 2017.
2
Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.比较既往透明角膜超声乳化白内障吸除术后应用丝裂霉素 C 的小梁切除术与单纯白内障术后的结果。
J Glaucoma. 2013 Jan;22(1):52-9. doi: 10.1097/IJG.0b013e31821e8607.
3
Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.原发性小梁切除术联合丝裂霉素 C:2 年的安全性和疗效。
Clin Exp Ophthalmol. 2010 Dec;38(9):831-8. doi: 10.1111/j.1442-9071.2010.02349.x.
4
Deep sclerectomy with mitomycin C in failed trabeculectomy.小梁切除术后失败病例行丝裂霉素C深层巩膜切除术。
Eye (Lond). 2007 Jan;21(1):23-8. doi: 10.1038/sj.eye.6702183. Epub 2005 Nov 25.
5
Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.重复小梁切除术联合高剂量丝裂霉素 C 的手术效果。
Indian J Ophthalmol. 2019 Jan;67(1):95-100. doi: 10.4103/ijo.IJO_682_18.
6
Protocol for mitomycin C use in glaucoma surgery.青光眼手术中丝裂霉素C的使用方案。
Acta Ophthalmol Scand. 2005 Apr;83(2):196-200. doi: 10.1111/j.1600-0420.2005.00437.x.
7
Trabeculectomy with brief exposure to mitomycin C.小梁切除术联合短暂暴露于丝裂霉素C
Clin Exp Ophthalmol. 2006 Nov;34(8):765-70. doi: 10.1111/j.1442-9071.2006.01305.x.
8
Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.超声乳化术后有晶状体眼与无晶状体眼的开角型青光眼行小梁切除术的前瞻性临床队列研究。
JAMA Ophthalmol. 2014 Jan;132(1):69-76. doi: 10.1001/jamaophthalmol.2013.5605.
9
Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.丝裂霉素C辅助小梁切除术:有晶状体性开角型青光眼的手术效果及失败风险因素
Ophthalmology. 2006 Jun;113(6):930-6. doi: 10.1016/j.ophtha.2006.01.062. Epub 2006 Apr 27.
10
[Trabeculectomy for normal-tension glaucoma].正常眼压性青光眼的小梁切除术
Nippon Ganka Gakkai Zasshi. 1994 Jun;98(6):579-83.

引用本文的文献

1
The impact of intraocular pressure fluctuations on the progression of glaucoma and associated factors.眼压波动对青光眼进展的影响及相关因素
Adv Ophthalmol Pract Res. 2025 Mar 12;5(2):142-148. doi: 10.1016/j.aopr.2025.03.002. eCollection 2025 May-Jun.
2
Comparison of SENSIMED Triggerfish (TF) 24-Hour Monitoring in Open-Angle Glaucoma Patients Before and After Trabeculectomy.小梁切除术前、后开角型青光眼患者使用SENSIMED Triggerfish(TF)进行24小时监测的比较。
J Clin Med. 2025 Mar 19;14(6):2112. doi: 10.3390/jcm14062112.
3
Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis.

本文引用的文献

1
24-h Efficacy of Glaucoma Treatment Options.青光眼治疗方案的24小时疗效
Adv Ther. 2016 Apr;33(4):481-517. doi: 10.1007/s12325-016-0302-0. Epub 2016 Feb 24.
2
New perspectives on target intraocular pressure.目标眼内压的新视角。
Surv Ophthalmol. 2014 Nov-Dec;59(6):615-26. doi: 10.1016/j.survophthal.2014.04.001. Epub 2014 Apr 8.
3
Trabeculectomy for open-angle glaucoma in phakic eyes vs in pseudophakic eyes after phacoemulsification: a prospective clinical cohort study.超声乳化术后有晶状体眼与无晶状体眼的开角型青光眼行小梁切除术的前瞻性临床队列研究。
采用 iStent 技术行小梁微旁路植入术后青光眼的视野变化和功能进展率:一项荟萃分析。
BMJ Open Ophthalmol. 2024 Feb 15;9(1):e001575. doi: 10.1136/bmjophth-2023-001575.
4
Advances in Canaloplasty-Modified Techniques Yield Strong Pressure Reduction with Low Risk Profile.房角切开术改良技术的进展带来显著降压效果且风险较低。
J Clin Med. 2023 Apr 21;12(8):3031. doi: 10.3390/jcm12083031.
5
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.开角型青光眼小梁切除术的长期疗效:回顾性队列研究结果。
BMJ Open. 2023 Feb 3;13(2):e068403. doi: 10.1136/bmjopen-2022-068403.
6
Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES): Eleven Years of Follow-up.非洲裔人群青光眼及相关疾病研究(ADAGES)中的青光眼视野进展:十一年随访。
Am J Ophthalmol. 2022 Jul;239:122-129. doi: 10.1016/j.ajo.2022.02.003. Epub 2022 Feb 13.
7
Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma.单独植入2-3个小梁微旁路支架(iStent inject ± iStent)作为中度至重度青光眼小梁切除术的替代方法。
Ophthalmol Ther. 2022 Feb;11(1):271-292. doi: 10.1007/s40123-021-00424-4. Epub 2021 Nov 25.
8
Impact of intraocular pressure fluctuations on progression of normal tension glaucoma.眼压波动对正常眼压性青光眼进展的影响。
Int J Ophthalmol. 2021 Oct 18;14(10):1553-1559. doi: 10.18240/ijo.2021.10.12. eCollection 2021.
9
Long-Term Follow-Up After Successful Trabeculectomy: A Case Report of Reversal of Cupping and Recovery of Visual Field Progression.小梁切除术后的长期随访:一例视盘杯状凹陷逆转及视野进展恢复的病例报告
Cureus. 2021 Feb 23;13(2):e13520. doi: 10.7759/cureus.13520.
10
Efficacy and safety of XEN®-Implantation vs. trabeculectomy: Data of a "real-world" setting.XEN®-植入术与小梁切除术的疗效和安全性:“真实世界”环境下的数据。
PLoS One. 2020 Apr 20;15(4):e0231614. doi: 10.1371/journal.pone.0231614. eCollection 2020.
JAMA Ophthalmol. 2014 Jan;132(1):69-76. doi: 10.1001/jamaophthalmol.2013.5605.
4
[Are diurnal and nocturnal intraocular pressure measurements over 48 h justified?].[48小时内进行昼夜眼压测量是否合理?]
Ophthalmologe. 2013 Aug;110(8):755-8, 760. doi: 10.1007/s00347-012-2774-x.
5
Diurnal and nocturnal intraocular pressure fluctuations after trabeculectomy.小梁切除术后的昼夜眼压波动。
Ophthalmologica. 2012;227(3):160-5. doi: 10.1159/000333099. Epub 2011 Nov 10.
6
Comparative outcomes between newer and older surgeries for glaucoma.青光眼新旧手术方式的对比结果。
Trans Am Ophthalmol Soc. 2009 Dec;107:127-33.
7
Risk factors for glaucoma onset and progression.青光眼发病和进展的危险因素。
Surv Ophthalmol. 2008 Nov;53 Suppl1:S3-10. doi: 10.1016/j.survophthal.2008.08.006.
8
Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.在晚期青光眼干预研究中,眼压波动是低眼压状态下视野进展的一个风险因素。
Ophthalmology. 2008 Jul;115(7):1123-1129.e3. doi: 10.1016/j.ophtha.2007.10.031. Epub 2008 Feb 20.
9
Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.早期显性青光眼试验中眼压波动与青光眼进展情况
Ophthalmology. 2007 Feb;114(2):205-9. doi: 10.1016/j.ophtha.2006.07.060. Epub 2006 Nov 13.
10
Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension.日间眼压波动:并非高危眼压升高患者青光眼性视野缺损的独立危险因素。
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):513-8. doi: 10.1007/s00417-004-1103-8. Epub 2005 Mar 9.